Dr. Tanios Bekaii-Saab

Mayo Clinic Cancer Center researchers identify promising drug to treat gastrointestinal cancers

Research on adagrasib has demonstrated promising clinical activity in patients with gastrointestinal cancers that harbor KRAS G12C mutations.

COVID-19 accelerates telemedicine use in oncology practices

As coronavirus disease 2019 (COVID-19) challenges health care systems across the United States, it poses an extra challenge for physicians in the field of oncology. "Patients ...